Ticker Details
Vera Therapeutics, Inc.
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.44B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.79 | 3.31%
Avg Daily Range (30 D):	$0.92 | 2.38%
Avg Daily Range (90 D):	$0.92 | 2.25%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	.95M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	2,236
Avg Institutional Trade:	$2.39M
Avg Institutional Trade (30 D):	$2.96M
Avg Institutional Trade (90 D):	$3.07M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.9M
Avg Closing Trade (30 D):	$5.6M
Avg Closing Trade (90 D):	$6.03M
Avg Closing Volume:	123.5K

News

Apr 29, 2026 @ 5:00 PM IgA Nephropathy Market Forecast to 2036: Novel The... Source: Delveinsight

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Mar 13, 2026 @ 2:36 PM This Fund Bet $200 Million on a Biotech Stock Up 5... Source: Jonathan Ponciano

Mar 5, 2026 @ 2:00 PM Vera Therapeutics Appoints Christopher Hite to Boa... Source: Not Specified

Dec 10, 2025 @ 1:57 AM Vera Therapeutics Announces Pricing of Public Offe... Source: Vera Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-5.54	$-1.69	$-1.39
Diluted EPS	$-5.54	$-1.69	$-1.39
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-368.95M	$-121.03M	$-91.1M
Operating Income / Loss	$-383.41M	$-125.13M	$-94.21M
Cost of Revenue
Net Cash Flow	$59.26M	$-240.37M	$296.95M
PE Ratio